V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006184 | 200006184 | null | null | null | null | 2018-11-05 | CHLORAMBUCIL + RITUXIMAB | null | null | IPILIMUMAB + NIVOLUMAB | 101842692 |
| 200006188 | 200006188 | null | null | Adjuvant (A) | null | 2014-06-28 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100939256 |
| 200006191 | 200006191 | null | null | null | null | 2020-11-20 | null | null | null | DABRAFENIB + TRAMETINIB | 101616378 |
| 200006192 | 200006192 | null | null | null | 2018-07-30 | 2018-08-08 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100854454 |
| 200006193 | 200006193 | null | null | Curative (C) | 2019-05-07 | 2019-06-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | DABRAFENIB + TRAMETINIB | 100399459 |
| 200006203 | 200006203 | null | null | null | null | 2020-07-05 | DABRAFENIB + TRAMETINIB | null | null | NIVOLUMAB | 101420823 |
| 200006208 | 200006208 | null | null | Palliative (P) | 2020-12-16 | 2020-12-17 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100852872 |
| 200006225 | 200006225 | null | null | Palliative (P) | 2021-03-22 | 2021-03-28 | null | 01 | null | BUSULFAN | 100866049 |
| 200006231 | 200006231 | null | null | null | null | 2021-01-15 | DABRAFENIB + TRAMETINIB | null | null | DABRAFENIB + TRAMETINIB | 100842729 |
| 200006240 | 200006240 | 1.78 | 0 | Palliative (P) | 2019-12-06 | 2019-12-22 | null | 02 | N | BENDAMUSTINE + RITUXIMAB | 100727387 |
| 200006246 | 200006246 | null | null | null | null | 2018-04-15 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | PEMBROLIZUMAB | 100213999 |
| 200006248 | 200006248 | null | null | null | null | 2018-02-10 | Dacarbazine | null | null | DABRAFENIB + TRAMETINIB | 100887479 |
| 200006272 | 200006272 | 1.85 | 67 | Palliative (P) | 2018-01-27 | 2018-01-27 | null | N | N | PEMBROLIZUMAB | 100401756 |
| 200006275 | 200006275 | null | null | null | null | 2019-07-31 | DABRAFENIB + TRAMETINIB | null | null | PEMBROLIZUMAB | 101102053 |
| 200006276 | 200006276 | null | null | Curative (C) | 2018-08-15 | 2018-09-13 | PEMBROLIZUMAB | 02 | null | BINIMETINIB + ENCORAFENIB | 101770248 |
| 200006294 | 200006294 | null | null | null | null | 2019-05-17 | DABRAFENIB + TRAMETINIB | null | null | INTERIM TRIAL | 100777524 |
| 200006297 | 200006297 | null | null | Curative (C) | 2020-02-02 | 2020-02-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | DACARBAZINE | 101028212 |
| 200006316 | 200006316 | 1.66 | 89.3 | Palliative (P) | 2016-05-15 | 2016-06-04 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100843106 |
| 200006318 | 200006318 | null | null | Palliative (P) | 2018-07-11 | 2018-07-16 | null | 02 | null | PEMBROLIZUMAB | 101353349 |
| 200006324 | 200006324 | null | null | Disease modification (D) | 2013-08-28 | 2013-08-29 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101699237 |
| 200006348 | 200006348 | null | null | Curative (C) | null | 2017-11-02 | null | 02 | null | IPILIMUMAB | 100919321 |
| 200006354 | 200006354 | null | null | Palliative (P) | 2017-11-15 | 2017-11-22 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100576018 |
| 200006365 | 200006365 | null | null | 03 | 2019-04-13 | 2019-05-01 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 101184290 |
| 200006366 | 200006366 | null | null | Palliative (P) | null | 2019-10-02 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101498486 |
| 200006384 | 200006384 | 1.82 | 94.15 | Curative (C) | 2017-06-03 | 2017-06-12 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB | 100011917 |
| 200006385 | 200006385 | null | null | Palliative (P) | 2019-02-08 | 2019-02-24 | BENDAMUSTINE + RITUXIMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101751732 |
| 200006389 | 200006389 | null | null | null | null | 2020-11-03 | IPILIMUMAB + NIVOLUMAB | null | null | NIVOLUMAB | 100496681 |
| 200006407 | 200006407 | null | null | Palliative (P) | 2016-09-06 | 2016-09-09 | null | 02 | N | IPILIMUMAB | 100960974 |
| 200006413 | 200006413 | null | null | 03 | 2019-04-27 | 2019-04-29 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101825600 |
| 200006424 | 200006424 | 1.5 | 90.5 | Palliative (P) | 2016-09-15 | 2016-09-20 | Rituximab | 02 | null | DABRAFENIB + TRAMETINIB | 100859126 |
| 200006428 | 200006428 | null | null | null | null | 2019-06-25 | Trial Unspecified | null | null | PEMBROLIZUMAB | 100329990 |
| 200006442 | 200006442 | null | null | null | null | 2019-07-28 | IPILIMUMAB + NIVOLUMAB | null | null | TRIAL UNSPECIFIED | 101530100 |
| 200006450 | 200006450 | null | null | Palliative (P) | 2016-08-25 | 2016-09-09 | IPILIMUMAB + NIVOLUMAB | 02 | null | DABRAFENIB | 100159130 |
| 200006475 | 200006475 | null | null | null | null | 2016-09-29 | DABRAFENIB + TRAMETINIB | null | null | IPILIMUMAB + NIVOLUMAB | 101028036 |
| 200006485 | 200006485 | null | null | null | null | 2020-08-17 | null | null | null | NIVOLUMAB | 100422269 |
| 200006486 | 200006486 | null | null | Palliative (P) | 2017-03-07 | 2017-03-19 | null | 02 | null | DABRAFENIB + TRAMETINIB | 101541767 |
| 200006497 | 200006497 | null | null | null | null | 2017-02-28 | IDELALISIB + RITUXIMAB | null | null | IPILIMUMAB + NIVOLUMAB | 100538394 |
| 200006499 | 200006499 | null | null | Palliative (P) | 2017-12-08 | 2017-12-21 | IPILIMUMAB + NIVOLUMAB | 02 | N | DABRAFENIB + TRAMETINIB | 100485505 |
| 200006511 | 200006511 | null | null | null | null | 2016-01-28 | null | null | null | TRIAL | 100323449 |
| 200006522 | 200006522 | null | null | null | null | 2016-10-24 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101722528 |
| 200006531 | 200006531 | null | null | Palliative (P) | 2017-07-30 | 2017-08-04 | DABRAFENIB + TRAMETINIB | 02 | null | NIVOLUMAB | 100702685 |
| 200006539 | 200006539 | null | null | Palliative (P) | 2019-02-11 | 2019-02-21 | NIVOLUMAB | 02 | null | PEMBROLIZUMAB | 101660779 |
| 200006546 | 200006546 | null | null | Palliative (P) | 2019-06-12 | 2019-06-15 | null | 02 | null | NIVOLUMAB | 101028105 |
| 200006550 | 200006550 | null | null | 03 | 2020-02-04 | 2020-02-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | NIVOLUMAB | 100835305 |
| 200006551 | 200006551 | null | null | Palliative (P) | 2022-01-31 | 2022-02-26 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101028608 |
| 200006552 | 200006552 | 1.45 | 72.3 | null | null | 2019-05-14 | Enzalutamide | null | null | TRIAL UNSPECIFIED | 100307463 |
| 200006563 | 200006563 | null | null | null | null | 2016-02-15 | IPILIMUMAB + NIVOLUMAB | null | null | INTERIM TRIAL | 101400001 |
| 200006566 | 200006566 | null | null | Palliative (P) | 2016-06-17 | 2016-06-26 | IPILIMUMAB + NIVOLUMAB | 02 | N | PALBOCICLIB | 100682293 |
| 200006578 | 200006578 | null | null | Palliative (P) | 2019-08-01 | 2019-08-01 | NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100467632 |
| 200006587 | 200006587 | null | null | null | null | 2019-07-19 | null | null | null | NIVOLUMAB | 100894045 |